AbelJ.J., RountreeL.G., TurnerB.B.. On the removal of diffusible substances from the circulating blood of living animals by dialysis.J Pharmacol Exp Ther1914; 5: 275–316.
2.
GarellaS.. Extracorporeal techniques in the treatment of exogenous intoxications.Kidney Int1988; 33: 735–40.
3.
KatzbergR.W.. Urography into the 21st century: New contrast media, renal handling, imaging characteristics, and nephrotoxicity.Radiology1997; 204: 297–312.
KierdorfH., KindlerJ., WinterscheidR., HollmanH.J., VorwerkD., SpeckU.. Elimination of the nonionic contrast medium iopromide in end stage renal failure by hemodialysis.Fortschr Geb Rontgenstr Nuklearmed Erganzungsband1989; 128: 119–23.
6.
BeckerJ.A., BerdonW.E.. Blood clearance of contrast material in patients with impaired renal function.Radiology1969; 93: 1301–4.
7.
LoveL., LindJ.A., OlsonM.C.. Persistent CT nephrogram significance in the diagnosis of contrast nephropathy.Radiology1989; 172: 125–9.
8.
SolomonR., WernerC., MannD., D'EliaJ., SilvaP.. Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radiocontrast agents.N Engl J Med1994; 331: 1416–20.
9.
TepelM., van Der GietM., SchwarzfeldC., LauferU., LiermannD., ZidekW.. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetyecysteine.N Engl J Med2000, 343: 180–4.
10.
FurukawaT., UedaJ., HigashinoK., TakahashiS., SakaguchiK., ImaiT.. Permeability of contrast media through hemodialysis membrane.Acta Radiologica1997; 38: 918–21.
11.
BahlmannJ., KrüskemperH.L.. Elimination of iodine-containing contrast media by haemodialysis.Nephron1973; 10: 250–5.
12.
EvansJ.R., CutlerR.E., ForlandS.C.. Pharmacokinetics of iothalamate in end stage renal disease.J Clin Pharmacol1988; 28: 826–30.
13.
FurukawaT., UedaJ., TakahashiS., SakaguchiK.. Elimination of low-osmolality contrast media by hemodialysis.Acta Radiologica1996; 37: 966–71.
MoonS.S., BackS-E, KurkusJ., Nilsson-EhleP.. Hemodialysis for elimination of the nonionic contrast medium Iohexol after angiography in patients with impaired renal function.Nephron1995; 70: 430–7.
16.
MatzkiesF.K., ReineckeH., TombachB.. Reduced iopromide elimination in hemodialysis with cuprophan membranes.Acta Radiologica2000; 41: 671–3.
17.
MuruveD.A., SteinmanT.I.. Contrast-induced encephalopathy and seizures in a patient with chronic renal insufficiency.Clin Nephrol1996; 45: 406–9.
18.
HarasawaH., YamazakiC., MasukiK.. Side effects and pharmacokinetics of nonionic contrast medium in hemodialyzed patients.Nippon Igaku Hoshasen Gakkai Zasshi1990; 50: 1524–31.
19.
YounathanC.M., KaudeJ.V., CookM.D., ShawG.S., PetersonJ.C.. Dialysis is not indicated immediately after administration of nonionic contrast agents in patients with end-stage renal disease treated by maintenance dialysis.AJR1994; 163: 1969–71.
20.
LehnertT., KellerE., GondolfK., SchäffnerT., PavenstadtH., SchollmeyerP.. Effect of haemodialysis after contrast medium administration in patients with renal insufficiency.Nephrol Dial Transplant1998: 13: 358–62.
